Time is Up!
Time's up
Taking the Myelofibrosis Clinical Trials Quiz will give you a summary introduction of the disease classifications, signs & symptoms, and reason for the cause. It will prepare you for unforeseen circumstances. Myelofibrosis (MF) is a sporadic bone marrow cancer caused due to the abnormality in the production and development of blood cells. It is a type of blood cancer known as “Myeloproliferative Neoplasms (MPNs).” The abnormal blood cells start flowing through the new cells, leaving no low ability to produce red blood cells, white blood cells, and platelets.
It is a type of chronic disease that can occur on its own as primary Myelofibrosis. The stem cells start getting self-damaged, knows as acquired mutation. Another type is secondary Myelofibrosis, which appears as the result of myeloproliferative disease, leading to anemia, weakness, fatigue, and enlarged spleen or liver. Research also states a rare situation of exposure to radiation and toxic chemicals like Benzene.
Why Myelofibrosis Clinical Trials Quiz?
Take this quiz to test your knowledge about myelofibrosis clinical trials, treatments and other important myelofibrosis clinical trials information.
About 18,000 people are affected by Myelofibrosis in the U.S.
An affected person must conduct a regular check-up with a Hematologist or Oncologist. In some cases, an individual can live symptom-free for years. While in another type, it proliferates over the years and affects the working organs.
How is Myelofibrosis treated?
If not treated on time, it can build up to a severe issue like acute myeloid leukemia (AML).
Myelofibrosis treats according to the severity of the situation. The symptom-free patients are always under observation, and a standard set of tests are conduct. In extreme conditions, a bone marrow transplant is performed. In this surgery, the diseased bone marrow replaces by the donors’ new cells.
Suppose the patient suffers from an enlarged spleen because it fails to release the red blood cells into the blood. For such patients, surgery is performed to remove the spleen, termed as splenectomy or radiation therapy.
In Myelofibrosis, most of the treatments are design for the cause of the disease. If the body fails to generate new blood cells, a doctor recommends blood transfusion and replaces all the blood cells with the new ones. In the situation of anemia, there are also prescribe drugs such as prednisone and danazol.
There is a continuous study to find a solution for Myelofibrosis or provide an alternate option to control it from spreading.